Phylogica Limited

ASX:PYC ISIN:AU000000PYC7

Phylogica Limited (Phylogica) is an Australia-based company principally engaged in the discovery and development of therapeutics directed at proteins and their interactions. The Company is engaged in the discovery of peptide-based drugs to treat inflammatory diseases.  
 
        

Lihat di Bahasa Lain

Berita

Laporan Pasar Australia 20 Desember 2010: IMX Resources (ASX:IXR) Meluncurkan Pengapalan Pertama Biji Tembaga Besinya ke Cina

🕔12/20/2010 1:30:00 PM 13070

Laporan Pasar Australia 20 Desember 2010 memuat: IMX Resources Limited (ASX:IXR) telah meluncurkan pengapalan pertamanya untuk biji tembaga besi ke Cina; Phylogica Limited (ASX:PYC) menanda tangani perjanjian kolaborasi danlisensi dengan Pfizer (NYSE:PFE); Copper Strike Limited (ASX:CSE) menerima hasil yang kuat untuk tembaga, perak, kobalt di Walford Creek, Queensland Baratlaut; Produksi biji besi South American Ferro Metals Limited (ASX:SFZ) di Brazil melampaui 400.000 ton.

Baca Full Story▸
###

85,012 TAMPILAN PROFIL PERUSAHAAN

  • Halaman ini dilihat: (7 Hari Terakhir: 26) (30 Hari Terakhir: 109) (Sejak Ditampilkan: 8881) 

Data Perusahaan

    Fax
  • 08 9423 8899 
    • Sektor Utama
  • Kesehatan & Pharm 
    • Industri Utama
  • Biotechnology 
    • Homepage
  • www.phylogica.com/

Lebih banyak Berita lagi

  • 2024/09/26: E&P Healthcare Conference Presentation*
  • 2024/08/30: FDA Grants Rare Pediatric Disease Designation to PYC-001*
  • 2024/08/30: Q3 2024 Investor Webinar Presentation*
  • 2024/08/29: Appendix 4E and Audited Financial Statements*
  • 2024/08/22: Q3 Investor Webinar 30 August 2024*
  • 2024/08/15: PYC to Start Human Trials in Second Blinding Eye Disease*
  • 2024/08/13: Canaccord Genuity Growth Conference Presentation*
  • 2024/08/12: Visual Improvement in Multiple RP11 Patients*
  • 2024/08/05: RP11 Clinical Trial Update - Amended*
  • 2024/08/05: RP11 Clinical Trial Update*
*refer to company website